Observations placeholder
Abilify and Aripiprazole
Identifier
001491
Type of Spiritual Experience
Number of hallucinations: 1421
Background
A description of the experience
Abilify – also known as aripiprazole is an atypical antipsychotic. and antidepressant used in the treatment of schizophrenia, bipolar disorder, and clinical depression. It is a very complex product being a D2 agonist, a D3 antagonist, a D4 antagonist, as well as being an antihistamine, an alpha-adrenergic antagonist, mACh receptor antagonist and acting on serotonergic receptors [5-HT1A Partial Agonist , 5-HT2A Antagonist, 5-HT2C Partial Agonist , 5-HT7 Antagonist ]. It has a high incidence of hallucinations. It also has a lot of other side effects
On Dec, 26, 2016 49,809 people reported to have side effects when taking Abilify. Among them, 676 people (1.36%) have Hallucination
On Dec, 28, 2016 49,809 people reported to have side effects when taking Abilify.
Among them, 487 people (0.98%) have Hallucination, Auditory
On Jan, 03, 2017 49,809 people reported to have side effects when taking Abilify. Among them, 8 people (0.02%) have Hallucination, Olfactory
On Dec, 29, 2016 49,809 people reported to have side effects when taking Abilify.
Among them, 10 people (0.02%) have Hallucination, Tactile
On Jan, 27, 2017 6,271 people reported to have side effects when taking Aripiprazole.
Among them, 92 people (1.47%) have Hallucination
On Jan, 27, 20176,271 people reported to have side effects when taking Aripiprazole.
Among them, 148 people (2.36%) have Hallucination, Auditory